Authors : Adedosu Olaniyi Temitope; Adeleke Gbadebo Emmanuel; Badmus Jelili Abiodun; Akinboro Adetayo; Adedosu Akinola Nelson; Akintola Adebola; Babatunde Adetunji Ayodele; Ogunsina Faith Ayotunde; Oyedeji Tolulope Adejoke; Afolabi Adeniyi Stephen; Masaudat Adeola Adebayo; Emmanuel Olatunde Olagoke

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/yn3tvtcd

Scribd : https://tinyurl.com/4u4bb5dj

DOI : https://doi.org/10.38124/ijisrt/25aug1397

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Tissue toxicity have been linked to oxidative damage elicited by orthodox anti-cancer agents. Bioactive components from plants are used locally for treatment of cancer. This study evaluated the roles of ethyl acetate extract of Lannae egregia (EELE) leaf, a local anticancer plant of West Africa following methotrexate administration in rats. Thirty- two male Wistar rats averagely weighing 150g used for this study were acclimatized and randomly selected into four groups, A-D and treated: Group A (Control), Group B (Methotrexate only,2.5mg/kg.bw at 3 days interval for 21 days), group C (pre-treated extract at 100mg/kg.bw. daily for 14 days, challenged with 2.5mg/kg.bw of Methotrexate for 21 days at 3 days interval), group D (extract only at100mg/kg.bw daily), all carried out orally in 0.1 ml solution for 35days.Antioxidants, lipids profile, liver and kidney indices were determined using standard methods. Results showed that methotrexate significantly (p<0.05) decreases liver and kidney Superoxide dismutase, Catalase and Glutathione peroxidase activities, reduced glutathione and total protein levels with corresponding significant (p<0.05) increases in malondialdehyde concentrations and percentage fragmented DNA. In contrast, combined treatment with extract (group C) and extract alone (group D) showed improved metabolic alterations as these were reversed comparably with control. Results of lipid profile, liver and kidney indices showed elevated levels of plasma total triglyceride and cholesterol accompanied with attenuated level of high density lipoprotein cholesterol (HDL-c)while activities of Gamma-glutamyltransferase (γ-GT), Alanine aminotransferase (ALT), Aspartate aminotransferase (AST) and Alkaline Phosphatase (ALP) , as well as levels of bilirubin , plasma creatinine and urea were significantly (p<.05) increased in group B,which were reversed by group C. Results are suggestive of toxic effect of methotrexate via induction of oxidative stress while extract exhibited antioxidative and tissue protective potentials suggestive of its rich-bioactive contents and thus validating its medicinal values and as potential adjunct in cancer management.

Keywords : Methotrexate; Redox Imbalance; Antioxidative; Lannae Egregia; Cancer Management; Tissue Protective.

References :

1. Moore, D E. Drug-induced cutaneous photosensitivity. Drug safety, 2002,25(5), pp.345-372.
2. Adedosu, O.T., Adeleke, G.E., Badmus, J.A., Ojeleye, I.A. and Fatoberu, A.H. Anti- inflammatory and Anti-oxidative Effects of Flavonoids-rich Extract of Cymbopogoncitratus in Sodium Nitrite (NaNO2) Induced Oxidative Stress in Wistar Rats. Annual Research & Review in Biology, 2017, pp.1-11.
3. Lobo, V., Patil, A., Phatak, A. and Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy reviews, 2010,4(8), p.118.
4. Devasagayam, T.P.A., Tilak, T.P.A., Boloor, J.C., Sane, K.K., Ghaskadbi, K.S., and Lele, R.D. Free radicals and antioxidants in human health: current status and future prospects, Journal of Association of Physicians of India,2004, 52, pp. 794–804
5. Magee, D.J., Jhanji, S., Poulogiannis, G., Farquhar-Smith, P. and Brown, M.R.D. Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence. British journal of anaesthesia,2019, 123(2), pp. e412-e423.
6. Deavall, D.G., Martin, E.A., Horner, J.M. and Roberts, R. Drug-induced oxidative stress and toxicity. Journal of toxicology, 2012. (1),645460.
7. Uzar, E., Sahin, O., Koyuncuoglu, H.R., Uz, E., Bas, O., Kilbas, S., Yilmaz, H.R., Yurekli, V.A., Kucuker, H. and Songur, A. The activity of adenosine deaminase and the level of nitric oxide in spinal cord of methotrexate administered rats: protective effect of caffeic acid phenethyl ester. Toxicology, 2006,218(2-3), pp.125- 133.
8. Cetinkaya, A., Bulbuloglu, E., Kurutas, E.B. and Kantarceken, B.  N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Medical science monitor, 2006, 12(8), pp.BR274-BR278.
9. Mahoney Jr, D.H., Shuster, J.J., Nitschke, R., Lauer, S.J., Steuber, C.P., Winick, N. and Camitta, B. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. Journal of Clinical Oncology, 1998,16(5), pp.1712-1722.
10. Coleshowers, C.L., Oguntibeju, O.O., Ukpong, M. and Truter, E.J. Effects of methotrexate on antioxidant enzyme status in a rodent model: peer reviewed original article. Medical Technology SA,2010, 24(1), pp.4-9.
11. Gressier, B., Lebegue, S., Brunet, C., Luyckx, M., Dine, T., Cazin, M. and Cazin, J.C.  Pro-oxidant properties of methotrexate: evaluation and prevention by an anti- oxidant drug. Die Pharmazie,1994, 49(9), pp.679-681.
12. Kishi, S., Griener, J., Cheng, C., Das, S., Cook, E.H., Pei, D., Hudson, M., Rubnitz, J., Sandlund, J.T., Pui, C.H. and Relling, M.V. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. Journal of Clinical Oncology,2003, 21(16), pp.3084-3091.
13. Linnebank, M., Pels, H., Kleczar, N., Farmand, S., Fliessbach, K., Urbach, H., Orlopp, K., Klockgether, T., Schmidt-Wolf, I.G.H. and Schlegel, U. MTX-induced white matter changes are associated with polymorphisms of methionine metabolism. Neurology,2005, 64(5), pp.912-913.
14. Uz, E., Öktem, F., Yılmaz, H.R., Uzar, E. and Özgüner, F. The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Molecular and cellular biochemistry, 2005,277(1), pp.165-170.
15. Ekor, M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in pharmacology, 2014, 4, p.177.
16. Saranya, B., Sulfikarali, T., Chindhu, S., Muneeb, A.M., Leela, N.K. and Zachariah, T.J. Turmeric and cinnamon dominate in antioxidant potential among four major spices. Journal of Spices and Aromatic Crops,2017, 26(1), pp.27-32.
17. Pinchuk, I., Shoval, H., Dotan, Y. and Lichtenberg, D. Evaluation of antioxidants: scope, limitations and relevance of assays. Chemistry and physics of lipids, 2012,165(6), pp.638-647.
18. Shori, A.B. Screening of antidiabetic and antioxidant activities of medicinal plants. Journal of integrative medicine,2015, 13(5), pp.297-305.
19. Rafiu, B.O., Adesanya, E.O. and Sonibare, A.M. Phytochemical screening, antimicrobial and antioxidant studies of Lannea egregia Engl. and K. Krause (Anacardiaceae) stem bark. Journal of Medicinal Plants for Economic Development, 2019, 3(1), pp.19.
20. Soladoye, M.O., Amusa, N.A., Raji-Esan, S.O., Chukwuma, E.C. and Taiwo, A.A. Ethnobotanical survey of anti-cancer plants in Ogun State, Nigeria. Annals of biological research, 2010, 1(4), pp.261-273.
21. Burkill, H.M. The useful plants of West Tropical Africa.1985, Vol.1. Families AD (No. Ed. 2). Royal Botanic Gardens.
22. Arbonnier, M. Trees, shrubs and lianas of West African dry zones.,2004 Quae.
23. Neuwinger, H.D., 2000. African traditional medicine: a dictionary of plant use and applications. With supplement: search system for diseases.
24. Jin, Y. and Manabe, T. Differences in protein distribution between human plasma preparations, EDTA‐plasma and heparin‐plasma, analyzed by non‐denaturing micro‐2‐DE and MALDI‐MS PMF. Electrophoresis,2009, 30(6), pp.931-938
25. Ohkawa, H., Ohishi, N. and Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 1979,95(2), pp.351- 358.
26. Andersen, H.R., Nielsen, J.B., Nielsen, F. and Grandjean, P. Antioxidative Enzyme activities in human erythrocytes. Clinical chemistry, 1997,43(4), pp.562-568.
27. Anderson, M.E.  Determination of glutathione and glutathione disulfide in biological samples. Methods in enzymology, 1985,113, pp.548-555.
28. Misra, H.P. and Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological chemistry, 1975,247(10), pp.3170-3175.
29. Dominiczak, M.H. 1998 Teaching and training laboratory professionals for the 21^st century.   Clinical Chemistry and laboratory Medicine ,1998, 36 ,133-136
30. Wu D.H., Leung Y.K., Thomas M.A. 2011. Bisphenol A (BPA) confers direct genotoxicity to sperm with increased sperm DNA fragmentation. Fertil Steril. 2011;96: S5-6.
31. Naito H.K., Kaplan A. Clinical Chemistry. The CV.Mosby. Cost. Louis, Toronto. Princeton. 1984, 437:1194-11206.
32. Buccolo G and David H. Quantitative determination of serum triglyceride by the use of enzymes. Clin. Chem.1973,19:476-482
33. Szasz, G. A kinetic photometric method for serum gamma- glutamyl transpeptidase. Clin. Chem. 1969,15:124-136.
34. Young   D.S.Effects of diseases on Clinical Lab.Texts,4^th ed. AACC 2001.
35. Karmen, A. Serum and plasma Aspartate aminotransferase determination. J Clin. Invest.1995,24,126.
36. Wenger, C. Alkaline Phosphatase. Clinical Chemistry. 1984, 1094-1098
37. Kaplan A.  Bilirubin   Clinical Chemistry, published in the C.V. Mosby Co., St Louis, Toronto, 1984, pages 436, 1238-1241
38. Miller W., Myers G., Ashwood E. Creatinine measurement: state of the art in Accuracy and laboratory harmonization. Arch. Pathol. Lab. Med. 2005,129(3):297-304.
39. Fatoki, J.O., Adedosu, O.T., Afolabi, O.K., Adeleke, G.E., Adedeji, A.L., Ige, S.F., Adesope, E.O., Oyewole, O.V., Daramola, A.D. and Badmus, J.A. Dyslipidemic effect of doxorubicin and etoposide: a predisposing factor for the antineoplastic drugs-induced cardiovascular diseases. Research & Reviews: Journal of Pharmacology and Toxicological Studies, 2018,6(1), pp.34-42.
40. Gaies, E., Jebabli, N., Trabelsi, S., Salouage, I., Charfi, R., Lakhal, M. and Klouz, A. Methotrexate side effects: review article. Journal of Drug Metabolism and Toxicology, 2012, 3(4), pp.1-5.
41. Rajnics, P., Kellner, V.S., Kellner, A., Karadi, E., Kollar, B. and Egyed, M. The hematologic toxicity of methotrexate in patients with autoimmune disorders. J Neoplasm, 2017,2(1), pp.1-6.
42. Yiang, G.T., Chou, P.L., Hung, Y.T., Chen, J.N., Chang, W.J., Yu, Y.L. and Wei, C.W. Vitamin C enhances anticancer activity in methotrexate‑treated Hep3B hepatocellular carcinoma cells. Oncology reports, 2014,32(3s), pp.1057-1063.S
43. Wu, X., Cheng, J. and Wang, X. Dietary antioxidants: potential anticancer agents. Nutrition and cancer, 2017,69(4), pp.521-533.
44. Kohen, R. and Nyska, A. Invited review: Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic pathology, 2002,30(6), pp.620-650.
45. Mathew, J.E., Mantri, A.N.A.N.D., Vachala, S.D., Srinivasan, K.K. and Movaliya, V.I.N.I.T. Effect of Sphaeranthusindicus ethanol extract on tissue antioxidant activity in gentamicin induced nephrotoxic rats. HerbaPolonica, 2009,55(4), pp.86-95.
46. Bray, R.C., Cockle, S.A., Fielden, E.M., Roberts, P.B., Rotilio, G. and Calabrese, L. Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochemical Journal,1974, 139(1), pp.43-48.
47. Pigeolet, E., Corbisier, P., Houbion, A., Lambert, D., Michiels, C., Raes, M., Zachary, M.D. and Remacle, J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mechanisms of ageing and development,1990, 51(3), pp.283-297.
48. Halliwell, B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? The lancet, 1994, 344(8924), pp.721-724.
49. Dickinson, D.A., Moellering, D.R., Iles, K.E., Patel, R.P., Levonen, A.L., Wigley, A., Darley-Usmar, V.M. and Forman, H.J. Cytoprotection against oxidative stress and the regulation of glutathione synthesis. 2003,
50. Jahovic, N., Çevik, H., Şehirli, A.Ö., Yeğen, B.Ç. and Şener, G. Melatonin prevents methotrexate‐induced hepatorenal oxidative injury in rats. Journal of pineal research,2003, 34(4), pp.282-287.
51. Rietjens, I.M., Boersma, M.G., de Haan, L., Spenkelink, B., Awad, H.M., Cnubben, N.H., van Zanden, J.J., van der Woude, H., Alink, G.M. and Koeman, J.H. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environmental toxicology and pharmacology,2002, 11(3-4), pp.321-333.
52. Heaney, M.L., Gardner, J.R., Karasavvas, N., Golde, D.W., Scheinberg, D.A., Smith, E.A. and O'Connor, O.A. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer research, 2008, 68(19), pp.8031-8038.
53. Birben, E., Sahiner, U.M., Sackesen, C., Erzurum, S. and Kalayci, O. Oxidative stress and antioxidant defence. World Allergy Organization Journal, 2012, 5(1), pp.9-19.
54. Bortner, C.D., Oldenburg, N.B. and Cidlowski, J.A. The role of DNA fragmentation in apoptosis. Trends in cell biology, 1995, 5(1), pp.21-26.
55. Chabner, B. Pharmacologic principles of cancer treatment. WB Saunders Company.1982.
56. Vetvicka, V. and Vetvickova, J. Combination of glucan, resveratrol and vitamin C demonstrates strong anti-tumor potential. Anticancer Research,2012, 32(1), pp.81-87.
57. Guerriero, E., Sorice, A., Capone, F., Napolitano, V., Colonna, G., Storti, G., Castello, G. and Costantini, S. Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines. PLoS One, 2014, 9(12), p.e115287.
58. Hockenberry M.J.,Taylor O.A.., Pasvogel A., Rodgers C., McCarthy K., Grundy P., More I. The influence of oxidative stress on symptom, occurrence,severity and distress during childhood leukemia treatment. Oncology Nursing Forum, 2014,41, E238-E247.
59. Feingold K.R. Lipid and lipoprotein metabolism. Review Article. Endocrine and metabolism Clinics. 2022,51(3)437-458.
60. Medinat Y.A.,Jane I.E.,Musa I.Y. Acute and chronic toxicity profiles of the methanol leaf extract of Acacia Ataxacantha DC (Leguminosae) in Wistar rats. Bulletin of faculty of Pharmacy, Cairo University. 2018,56: 185-189.
61. Attyah A.M and Ismail   S.H. Protective effect of ginger extract against cisplatin-induced hepatotoxicity and cardiotoxicity in rats. Iraqi journal of pharmaceutical sciences. 2017, 21(1)21-33.
62. Lawrenz-Wolf B., Wolfrom C., Frickel C., Fengler R., Wehinger H., Henze G. 1994. Severe renal impairment of methotrexate after high dose therapy. Klinische Padiatrie. 1994,206(4):319-326.
63. Kohchale S 2015, Effects of folic acid antagonist methotrexate on seminal vesicle of Indian palm Squirrel Funambulus pennanti (Wroughton). Int.  Journal   of life Sciences, special issue A3. 2015, 89-91.